|
CENPE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.08999999998338E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.436900E-03 |
| Normal-vs-Stage2 |
1.743990E-01 |
| Normal-vs-Stage3 |
2.238400E-04 |
| Normal-vs-Stage4 |
3.632400E-02 |
| Stage1-vs-Stage2 |
5.288000E-01 |
| Stage1-vs-Stage3 |
4.941700E-03 |
| Stage1-vs-Stage4 |
1.003000E-01 |
| Stage2-vs-Stage3 |
2.142400E-01 |
| Stage2-vs-Stage4 |
3.176600E-01 |
| Stage3-vs-Stage4 |
8.616000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.40659999999338E-05 |
| Normal-vs-AfricanAmerican |
2.787700E-02 |
| Normal-vs-Asian |
1.550230E-01 |
| Caucasian-vs-AfricanAmerican |
6.346800E-01 |
| Caucasian-vs-Asian |
2.714000E-01 |
| AfricanAmerican-vs-Asian |
2.737000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.401560E-03 |
| Normal-vs-Female |
1.63965999999682E-05 |
| Male-vs-Female |
3.201800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.195070E-03 |
| Normal-vs-Extreme_Weight |
2.932300E-02 |
| Normal-vs-Obese |
1.857110E-03 |
| Normal-vs-Extreme_Obese |
3.341200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.179800E-02 |
| Normal_Weight-vs-Obese |
6.342400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.326100E-02 |
| Extreme_Weight-vs-Obese |
9.174300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.815200E-01 |
| Obese-vs-Extreme_Obese |
6.951900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.539500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.85845999999268E-05 |
| Normal-vs-Age(61-80Yrs) |
1.034240E-02 |
| Normal-vs-Age(81-100Yrs) |
1.541190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.173980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.391700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.608300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.078300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.513600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.718200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.375700E-02 |
| Normal-VS-Type2 PRCC |
8.159000E-04 |
| Normal-VS-KIRP CIMP |
9.023400E-03 |
| Normal-VS-Unclassified PRCC |
3.900000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.096400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.383920E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.393800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.380200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.368800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.410000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.237590E-02 |
| Normal-vs-N1 |
5.54039999989264E-07 |
| Normal-vs-N2 |
2.511200E-01 |
| N0-vs-N1 |
8.04550000000903E-05 |
| N0-vs-N2 |
2.359000E-01 |
| N1-vs-N2 |
4.945000E-01 |
|
|
